The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome

Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B ce...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 684999
Main Authors Du, Wenhan, Han, Man, Zhu, Xiaoxia, Xiao, Fan, Huang, Enyu, Che, Nan, Tang, Xiaopo, Zou, Hejian, Jiang, Quan, Lu, Liwei
Format Journal Article
LanguageEnglish
Published Frontiers Media S.A 08.06.2021
Subjects
B cells
Immunology
pathogenesis
primary Sjögren’s syndrome
regulatory functions
treatment
Online AccessGet full text

Cover

Abstract Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B cells highlight the critical involvement of B cells in disease development, the precise roles of various B cell subsets in pSS pathogenesis remain partially understood. Current studies have identified several novel B cell subsets with multiple functions in pSS, among which autoreactive age-associated B cells, and plasma cells with augmented autoantibody production contribute to the disease progression. In addition, tissue-resident Fc Receptor-Like 4 (FcRL4) + B cell subset with enhanced pro-inflammatory cytokine production serves as a key driver in pSS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas. Recently, regulatory B (Breg) cells with impaired immunosuppressive functions are found negatively correlated with T follicular helper (Tfh) cells in pSS patients. Further studies have revealed a pivotal role of Breg cells in constraining Tfh response in autoimmune pathogenesis. This review provides an overview of recent advances in the identification of pathogenic B cell subsets and Breg cells, as well as new development of B-cell targeted therapies in pSS patients.
AbstractList Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B cells highlight the critical involvement of B cells in disease development, the precise roles of various B cell subsets in pSS pathogenesis remain partially understood. Current studies have identified several novel B cell subsets with multiple functions in pSS, among which autoreactive age-associated B cells, and plasma cells with augmented autoantibody production contribute to the disease progression. In addition, tissue-resident Fc Receptor-Like 4 (FcRL4) + B cell subset with enhanced pro-inflammatory cytokine production serves as a key driver in pSS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas. Recently, regulatory B (Breg) cells with impaired immunosuppressive functions are found negatively correlated with T follicular helper (Tfh) cells in pSS patients. Further studies have revealed a pivotal role of Breg cells in constraining Tfh response in autoimmune pathogenesis. This review provides an overview of recent advances in the identification of pathogenic B cell subsets and Breg cells, as well as new development of B-cell targeted therapies in pSS patients.
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B cells highlight the critical involvement of B cells in disease development, the precise roles of various B cell subsets in pSS pathogenesis remain partially understood. Current studies have identified several novel B cell subsets with multiple functions in pSS, among which autoreactive age-associated B cells, and plasma cells with augmented autoantibody production contribute to the disease progression. In addition, tissue-resident Fc Receptor-Like 4 (FcRL4)+ B cell subset with enhanced pro-inflammatory cytokine production serves as a key driver in pSS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas. Recently, regulatory B (Breg) cells with impaired immunosuppressive functions are found negatively correlated with T follicular helper (Tfh) cells in pSS patients. Further studies have revealed a pivotal role of Breg cells in constraining Tfh response in autoimmune pathogenesis. This review provides an overview of recent advances in the identification of pathogenic B cell subsets and Breg cells, as well as new development of B-cell targeted therapies in pSS patients.Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B cells highlight the critical involvement of B cells in disease development, the precise roles of various B cell subsets in pSS pathogenesis remain partially understood. Current studies have identified several novel B cell subsets with multiple functions in pSS, among which autoreactive age-associated B cells, and plasma cells with augmented autoantibody production contribute to the disease progression. In addition, tissue-resident Fc Receptor-Like 4 (FcRL4)+ B cell subset with enhanced pro-inflammatory cytokine production serves as a key driver in pSS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas. Recently, regulatory B (Breg) cells with impaired immunosuppressive functions are found negatively correlated with T follicular helper (Tfh) cells in pSS patients. Further studies have revealed a pivotal role of Breg cells in constraining Tfh response in autoimmune pathogenesis. This review provides an overview of recent advances in the identification of pathogenic B cell subsets and Breg cells, as well as new development of B-cell targeted therapies in pSS patients.
Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as salivary glands. Although the formation of ectopic lymphoid tissue in exocrine glands and overproduction of autoantibodies by autoreactive B cells highlight the critical involvement of B cells in disease development, the precise roles of various B cell subsets in pSS pathogenesis remain partially understood. Current studies have identified several novel B cell subsets with multiple functions in pSS, among which autoreactive age-associated B cells, and plasma cells with augmented autoantibody production contribute to the disease progression. In addition, tissue-resident Fc Receptor-Like 4 (FcRL4)+ B cell subset with enhanced pro-inflammatory cytokine production serves as a key driver in pSS patients with mucosa-associated lymphoid tissue (MALT)-lymphomas. Recently, regulatory B (Breg) cells with impaired immunosuppressive functions are found negatively correlated with T follicular helper (Tfh) cells in pSS patients. Further studies have revealed a pivotal role of Breg cells in constraining Tfh response in autoimmune pathogenesis. This review provides an overview of recent advances in the identification of pathogenic B cell subsets and Breg cells, as well as new development of B-cell targeted therapies in pSS patients.
Author Han, Man
Xiao, Fan
Zou, Hejian
Zhu, Xiaoxia
Du, Wenhan
Lu, Liwei
Huang, Enyu
Che, Nan
Jiang, Quan
Tang, Xiaopo
AuthorAffiliation 3 Department of Rheumatology, Huashan Hospital and Fudan University , Shanghai , China
2 Division of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences , Beijing , China
4 Chongqing International Institute for Immunology , Chongqing , China
5 Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University , Jiangsu , China
1 Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong , Hong Kong , China
AuthorAffiliation_xml – name: 2 Division of Rheumatology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences , Beijing , China
– name: 1 Department of Pathology and Shenzhen Institute of Research and Innovation, The University of Hong Kong , Hong Kong , China
– name: 5 Department of Rheumatology, The First Affiliated Hospital of Nanjing Medical University , Jiangsu , China
– name: 4 Chongqing International Institute for Immunology , Chongqing , China
– name: 3 Department of Rheumatology, Huashan Hospital and Fudan University , Shanghai , China
Author_xml – sequence: 1
  givenname: Wenhan
  surname: Du
  fullname: Du, Wenhan
– sequence: 2
  givenname: Man
  surname: Han
  fullname: Han, Man
– sequence: 3
  givenname: Xiaoxia
  surname: Zhu
  fullname: Zhu, Xiaoxia
– sequence: 4
  givenname: Fan
  surname: Xiao
  fullname: Xiao, Fan
– sequence: 5
  givenname: Enyu
  surname: Huang
  fullname: Huang, Enyu
– sequence: 6
  givenname: Nan
  surname: Che
  fullname: Che, Nan
– sequence: 7
  givenname: Xiaopo
  surname: Tang
  fullname: Tang, Xiaopo
– sequence: 8
  givenname: Hejian
  surname: Zou
  fullname: Zou, Hejian
– sequence: 9
  givenname: Quan
  surname: Jiang
  fullname: Jiang, Quan
– sequence: 10
  givenname: Liwei
  surname: Lu
  fullname: Lu, Liwei
BookMark eNp1kU1uFDEQhS2UiISQA7DrJZsZ_P-zQYJRCEFBQSSsLbddPeNRd3uwu5GyyzVykVyAm3ASemaCRJCojUtV730q-b1AB33qAaFXBM8Z0-ZNE7tunFNMyVxqbox5ho6JlHzGKOUHf_VH6LSUNZ6KG8aYeI6OGCdSS8GO0aebFVSfx3aImxaqr6mFUqWmel8toG1LFftqmARf3LBKS-ihxN36ev3zYZmh_3V3X6rr2z7k1MFLdNi4tsDp43uCvn04u1l8nF1enV8s3l3OvMB6mPm6qQ2hSlNFmsYRIUBSTgLGoOtAQGvWCGx4rRiXwngTPPa1cpwIE-g0PUEXe25Ibm03OXYu39rkot0NUl5al4foW7BMu-BBCcqU4dwb4ykJVCrptA6CNhPr7Z61GesOJm0_ZNc-gT7d9HFll-mH1ZQorfEEeP0IyOn7CGWwXSx--jvXQxqLpYILYRQ3fJKqvdTnVEqGxvo4uCGmLTm2lmC7DdbugrXbYO0-2MlJ_nH-OfD_nt8jEqkR
CitedBy_id crossref_primary_10_3390_nu16040487
crossref_primary_10_1093_rheumatology_keae312
crossref_primary_10_1080_16078454_2023_2240138
crossref_primary_10_3389_fimmu_2024_1468469
crossref_primary_10_3389_fphar_2023_1093924
crossref_primary_10_1186_s13075_023_03070_2
crossref_primary_10_3390_jpm14090967
crossref_primary_10_1038_s10038_022_01107_z
crossref_primary_10_3390_ijms241311179
crossref_primary_10_2147_IJGM_S504780
crossref_primary_10_1016_j_jaut_2024_103326
crossref_primary_10_3389_fimmu_2024_1421436
crossref_primary_10_4081_gc_2022_10668
crossref_primary_10_32322_jhsm_1188641
crossref_primary_10_1016_j_imbio_2023_152726
crossref_primary_10_1016_j_jaut_2024_103341
crossref_primary_10_1038_s41598_023_40802_5
crossref_primary_10_3390_ijms241512209
crossref_primary_10_1007_s10067_022_06200_4
crossref_primary_10_3389_fvets_2024_1479363
crossref_primary_10_3390_diagnostics14182035
crossref_primary_10_3389_fimmu_2023_1023248
crossref_primary_10_1016_j_ygeno_2024_110952
crossref_primary_10_1186_s40364_025_00733_x
crossref_primary_10_1038_s41423_022_00933_7
crossref_primary_10_3390_ijms25063259
crossref_primary_10_1016_j_job_2023_06_002
crossref_primary_10_3389_fphar_2023_1189142
crossref_primary_10_1093_jleuko_qiad049
crossref_primary_10_3389_fphar_2024_1377055
crossref_primary_10_2147_JIR_S503309
crossref_primary_10_1016_j_jaci_2023_05_011
crossref_primary_10_1021_acsami_4c16595
crossref_primary_10_1016_j_exer_2023_109716
crossref_primary_10_2174_0118742106365620250210112737
crossref_primary_10_1186_s12967_024_05993_z
crossref_primary_10_1016_j_isci_2022_105509
crossref_primary_10_3390_ijms25147554
crossref_primary_10_1167_iovs_63_6_18
crossref_primary_10_1002_iid3_1244
crossref_primary_10_1016_j_jaut_2024_103291
crossref_primary_10_1007_s11302_022_09900_3
crossref_primary_10_1016_j_imlet_2024_106935
crossref_primary_10_2478_rir_2022_0035
crossref_primary_10_1016_j_mehy_2024_111422
Cites_doi 10.4049/jimmunol.0902385
10.1038/leu.2015.174
10.1084/jem.20050879
10.1002/eji.200636270
10.1111/ejh.12206
10.1084/jem.184.6.2271
10.1371/journal.pone.0179793
10.4049/jimmunol.179.7.4929
10.1016/j.clim.2017.12.005
10.1177/0961203319889666
10.4049/jimmunol.0803052
10.1016/j.clim.2016.02.009
10.1038/mtm.2016.13
10.1186/ar3220
10.1111/j.1365-3083.2010.02475.x
10.1111/sji.12718
10.1158/0008-5472.CAN-12-3450
10.1186/ar4245
10.1016/j.immuni.2020.04.015
10.1016/j.jaut.2013.11.003
10.1093/rheumatology/keaa695
10.1046/j.1365-2249.1999.00917.x
10.1186/ar4571
10.3109/08916934.2010.545847
10.1038/cmi.2017.8
10.1002/art.37828
10.1111/bjh.15120
10.1038/nm1763
10.4049/jimmunol.1601106
10.1111/cei.12639
10.1016/j.jaut.2017.03.012
10.1038/s41467-018-03750-7
10.1136/annrheumdis-2013-204584
10.7554/eLife.41641
10.1002/art.21129
10.1038/s41423-020-00540-4
10.1681/ASN.2010010034
10.4049/jimmunol.1002539
10.1136/annrheumdis-2019-216588
10.1097/RHU.0000000000000210
10.1038/s41423-021-00688-7
10.1038/nrneph.2016.20
10.3389/fimmu.2020.00032
10.1002/jcph.686
10.1002/art.11311
10.1191/0961203305lu2138oa
10.1186/ar3810
10.1002/path.1533
10.1186/ar2210
10.1038/nrrheum.2011.1
10.1093/rheumatology/37.7.779
10.1620/tjem.244.263
10.4049/jimmunol.1500055
10.1182/blood.V90.2.766
10.1146/annurev.immunol.25.022106.141541
10.1182/blood-2011-01-330357
10.7326/M13-1085
10.1182/blood-2005-06-2502
10.1111/trf.12614
10.4049/jimmunol.174.3.1438
10.1182/blood-2011-01-330530
10.1016/j.immuni.2009.11.009
10.1016/j.immuni.2018.06.007
10.4049/jimmunol.176.2.705
10.1177/0961203315585815
10.1038/s41423-019-0227-z
10.1002/art.10445
10.1073/pnas.1312348110
10.1038/nature12979
10.1016/j.coi.2018.09.012
10.1016/j.ajpath.2012.03.010
10.1016/j.clim.2016.04.008
10.1002/art.40215
10.1016/j.jaut.2020.102439
10.1172/JCI91250
10.1002/art.40059
10.1038/s41584-021-00605-2
10.1016/j.autrev.2007.01.010
10.1084/jem.20021293
10.1111/j.1749-6632.2012.06824.x
10.3389/fimmu.2017.00319
10.1093/intimm/dxl069
10.1136/annrheumdis-2013-203991
10.1186/ar3348
10.3899/jrheum.160313
10.1111/sji.12792
10.1093/rheumatology/keu532
10.1007/s10238-020-00637-0
10.1038/s41423-019-0308-z
10.1016/j.immuni.2014.10.016
10.1136/annrheumdis-2020-217646
10.1038/nrrheum.2010.118
10.3389/fimmu.2017.00768
10.1186/s13075-015-0551-3
10.1084/jem.20170901
10.1186/ar1912
10.3389/fimmu.2019.01368
10.1016/j.immuni.2018.08.015
10.1016/j.ebiom.2018.12.035
10.1016/S0140-6736(05)66990-5
10.3389/fimmu.2020.535784
10.1002/art.40093
10.1136/annrheumdis-2020-21748
10.1002/pbc.25172
10.1016/j.clim.2004.05.010
10.1016/j.jaut.2019.04.016
10.1016/j.jaci.2015.09.014
10.1093/rheumatology/kes080
10.1155/2016/4328372
10.1056/NEJMcp1702514
10.4049/jimmunol.1502448
10.1182/blood-2003-03-0692
10.1038/nm.3554
10.1002/art.39214
10.1182/blood-2011-01-331462
10.1182/blood-2010-07-294249
10.4049/jimmunol.0902551
10.1002/art.21936
10.1136/annrheumdis-2013-eular.284
10.1084/jem.186.10.1749
ContentType Journal Article
Copyright Copyright © 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu.
Copyright © 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu
Copyright_xml – notice: Copyright © 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu.
– notice: Copyright © 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu 2021 Du, Han, Zhu, Xiao, Huang, Che, Tang, Zou, Jiang and Lu
DBID AAYXX
CITATION
7X8
5PM
DOA
DOI 10.3389/fimmu.2021.684999
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList
CrossRef
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 1664-3224
ExternalDocumentID oai_doaj_org_article_38adce75237944c99c21d2676a88d52f
PMC8217880
10_3389_fimmu_2021_684999
GroupedDBID 53G
5VS
9T4
AAFWJ
AAKDD
AAYXX
ACGFO
ACGFS
ACXDI
ADBBV
ADRAZ
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
CITATION
DIK
EBS
EMOBN
GROUPED_DOAJ
GX1
HYE
KQ8
M48
M~E
OK1
PGMZT
RNS
RPM
7X8
5PM
ID FETCH-LOGICAL-c508t-cbfb91278271ffa155e6241d00e8bd1e883f5094b734659c9dc0cb7a4159d2b73
IEDL.DBID M48
ISSN 1664-3224
IngestDate Wed Aug 27 01:13:47 EDT 2025
Thu Aug 21 18:14:58 EDT 2025
Fri Jul 11 05:06:08 EDT 2025
Thu Apr 24 23:04:55 EDT 2025
Tue Jul 01 01:32:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c508t-cbfb91278271ffa155e6241d00e8bd1e883f5094b734659c9dc0cb7a4159d2b73
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
Edited by: Damo Xu, Shenzhen University, China
These authors have contributed equally to this work
This article was submitted to B Cell Biology, a section of the journal Frontiers in Immunology
Reviewed by: Ronghua Liu, Fudan University, China; Lauren Merlo, Lankenau Institute for Medical Research, United States; Efstathia K. Kapsogeorgou, National and Kapodistrian University of Athens, Greece
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fimmu.2021.684999
PMID 34168653
PQID 2545597494
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_38adce75237944c99c21d2676a88d52f
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8217880
proquest_miscellaneous_2545597494
crossref_citationtrail_10_3389_fimmu_2021_684999
crossref_primary_10_3389_fimmu_2021_684999
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-06-08
PublicationDateYYYYMMDD 2021-06-08
PublicationDate_xml – month: 06
  year: 2021
  text: 2021-06-08
  day: 08
PublicationDecade 2020
PublicationTitle Frontiers in immunology
PublicationYear 2021
Publisher Frontiers Media S.A
Publisher_xml – name: Frontiers Media S.A
References Bowman (B93) 2017; 69
Jakez-Ocampo (B86) 2015; 21
Cai (B115) 2015; 24
Daridon (B71) 2006; 54
Yates (B87) 2014; 54
Rubtsova (B52) 2017; 127
Szyszko (B39) 2011; 44
Kawano (B96) 1999; 116
Reincke (B70) 2020; 11
Rivière (B121) 2020; 79
Wang (B50) 2018; 9
Richter (B95) 2016; 5
Papp (B43) 2016; 2016
Taddeo (B82) 2015; 17
Xu (B4) 2020; 29
Szyszko (B36) 2011; 13
Furuzawa-Carballeda (B16) 2013; 15
Guo (B13) 2018; 88
Ramsköld (B27) 2019; 40
Soni (B59) 2020; 52
Haacke (B21) 2017; 81
Watanabe (B104) 2010; 184
Gomez (B81) 2011; 186
Xu (B113) 2017; 8
Marafioti (B54) 2003; 102
Zhao (B28) 2016; 56
Pontarini (B61) 2020; 79
Fox (B2) 2005; 366
Golinski (B57) 2020; 11
Gong (B122) 2014; 51
Hansen (B75) 2002; 46
Mariette (B1) 2018; 378
Voulgarelis (B5) 2010; 6
Jin (B37) 2014; 7
Rubtsova (B26) 2013; 110
Gomez (B89) 2012; 1274
Verstappen (B119) 2021; 17
Daridon (B9) 2007; 6
Demaria (B74) 2019; 184
Lindner (B112) 2013; 73
Ma (B12) 2020; 17
Royer (B73) 1997; 90
Lorenzetti (B32) 2019; 101
Jenks (B49) 2018; 49
Lin (B42) 2019; 16
Moldenhauer (B56) 2006; 107
Lin (B106) 2015; 74
He (B116) 2018; 244
Lavie (B64) 2004; 202
Mariette (B65) 2015; 74
Youinou (B10) 2011; 13
Xiao (B123) 2021; 18
Saulep-Easton (B110) 2016; 30
Ma (B77) 2020
Iwata (B101) 2011; 117
Yang (B109) 2010; 184
Ittah (B78) 2006; 8
Rosenberg (B84) 2016; 165
Fu (B107) 2018; 215
Chevalier (B97) 2020; 79
Claes (B51) 2016; 197
Verstappen (B48) 2017; 44
Theander (B7) 2015; 67
Fasano (B3) 2020; 38
Kanayama (B34) 2005; 174
Lino (B46) 2018; 49
Wang (B45) 2014; 20
Polson (B20) 2006; 18
Verstappen (B22) 2020; 109
Szyszko (B38) 2011; 73
Corneth (B30) 2017; 69
Rubtsov (B53) 2015; 195
Matsumoto (B102) 2014; 41
Cai (B117) 2015; 181
Wehr (B68) 2004; 113
Mauri (B103) 2003; 197
Blair (B41) 2010; 32
Shen (B44) 2014; 507
Lin (B14) 2014; 16
Rubtsov (B25) 2011; 118
Wang (B29) 2015; 54
Shen (B8) 2016; 168
Devauchelle-Pensec (B92) 2014; 160
Kiyama (B62) 2012; 14
Chambers (B47) 2005; 14
Ehrhardt (B18) 2005; 202
Hansen (B35) 2005; 52
Neubert (B83) 2008; 14
Fletcher (B72) 2006; 36
Davis (B17) 2007; 25
Glauzy (B33) 2017; 69
Hao (B24) 2011; 118
Mizoguchi (B98) 2006; 176
Jourdan (B19) 2017; 12
Carrillo-Ballesteros (B63) 2020; 20
Vosters (B79) 2012; 51
Saadoun (B67) 2013; 65
Rabani (B114) 2018; 188
Russell Knode (B31) 2017; 198
Fehres (B111) 2019; 10
Lim (B94) 2011; 118
Wolf (B99) 1996; 184
Adler (B11) 2017; 8
Simon (B15) 2016; 137
Salomonsson (B6) 2003; 48
Zumaquero (B58) 2019; 8
Mizoguchi (B100) 1997; 186
Yang (B108) 2012; 180
Hiepe (B91) 2011; 7
Chen (B60) 2020
Bontscho (B80) 2011; 22
Morva (B120) 2013; 72
Cuello (B23) 1998; 37
Bombardieri (B55) 2007; 179
Fillatreau (B118) 2018; 55
Wu (B66) 2019
Thorarinsdottir (B69) 2019; 90
Xiao (B40) 2017; 14
Mehta (B85) 2014; 61
Hansen (B76) 2007; 9
van Balen (B88) 2014; 92
Hiepe (B90) 2016; 12
Blair (B105) 2009; 182
References_xml – volume: 184
  year: 2010
  ident: B104
  article-title: Regulatory B Cells (B10 Cells) Have a Suppressive Role in Murine Lupus: CD19 and B10 Cell Deficiency Exacerbates Systemic Autoimmunity
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0902385
– volume: 30
  year: 2016
  ident: B110
  article-title: The BAFF Receptor TACI Controls IL-10 Production by Regulatory B Cells and CLL B Cells
  publication-title: Leukemia
  doi: 10.1038/leu.2015.174
– volume: 202
  year: 2005
  ident: B18
  article-title: Expression of the Immunoregulatory Molecule FcRH4 Defines a Distinctive Tissue-Based Population of Memory B Cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20050879
– volume: 36
  year: 2006
  ident: B72
  article-title: Development of Nephritis But Not Sialadenitis in Autoimmune-Prone BAFF Transgenic Mice Lacking Marginal Zone B Cells
  publication-title: Eur J Immunol
  doi: 10.1002/eji.200636270
– volume: 92
  year: 2014
  ident: B88
  article-title: Refractory Thrombotic Thrombocytopenic Purpura in a 16-Year-Old Girl: Successful Treatment With Bortezomib
  publication-title: Eur J Haematol
  doi: 10.1111/ejh.12206
– volume: 184
  year: 1996
  ident: B99
  article-title: Experimental Autoimmune Encephalomyelitis Induction in Genetically B Cell–Deficient Mice
  publication-title: J Exp Med
  doi: 10.1084/jem.184.6.2271
– volume: 12
  start-page: e0179793
  year: 2017
  ident: B19
  article-title: Characterization of Human FCRL4-Positive B Cells
  publication-title: PloS One
  doi: 10.1371/journal.pone.0179793
– volume: 179
  year: 2007
  ident: B55
  article-title: Activation-Induced Cytidine Deaminase Expression in Follicular Dendritic Cell Networks and Interfollicular Large B Cells Supports Functionality of Ectopic Lymphoid Neogenesis in Autoimmune Sialoadenitis and MALT Lymphoma in Sjögren’s Syndrome
  publication-title: J Immunol
  doi: 10.4049/jimmunol.179.7.4929
– volume: 188
  start-page: 45
  year: 2018
  ident: B114
  article-title: Il-21 Dependent Granzyme B Production of B-Cells Is Decreased in Patients With Lupus Nephritis
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2017.12.005
– volume: 29
  start-page: 45
  year: 2020
  ident: B4
  article-title: Characteristics of Chinese Patients With Primary Sjögren’s Syndrome: Preliminary Report of a Multi-Centre Registration Study
  publication-title: Lupus
  doi: 10.1177/0961203319889666
– volume: 182
  year: 2009
  ident: B105
  article-title: Selective Targeting of B Cells With Agonistic Anti-CD40 Is an Efficacious Strategy for the Generation of Induced Regulatory T2-Like B Cells and for the Suppression of Lupus in MRL/lpr Mice
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0803052
– volume: 165
  year: 2016
  ident: B84
  article-title: A Role for Plasma Cell Targeting Agents in Immune Tolerance Induction in Autoimmune Disease and Antibody Responses to Therapeutic Proteins
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2016.02.009
– volume: 5
  start-page: 16013
  year: 2016
  ident: B95
  article-title: Preclinical Safety, Pharmacokinetics, Pharmacodynamics, and Biodistribution Studies With Ad35K++ Protein: A Novel Rituximab Cotherapeutic
  publication-title: Mol Ther Methods Clin Dev
  doi: 10.1038/mtm.2016.13
– volume: 13
  start-page: R2
  year: 2011
  ident: B36
  article-title: Salivary Glands of Primary Sjögren’s Syndrome Patients Express Factors Vital for Plasma Cell Survival
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3220
– volume: 73
  start-page: 18
  year: 2011
  ident: B38
  article-title: Phenotypic Diversity of Peripheral Blood Plasma Cells in Primary Sjögren’s Syndrome
  publication-title: Scand J Immunol
  doi: 10.1111/j.1365-3083.2010.02475.x
– volume: 88
  start-page: e12718
  year: 2018
  ident: B13
  article-title: Aberrant IL-35 Levels in Patients With Primary Sjogren’s Syndrome
  publication-title: Scand J Immunol
  doi: 10.1111/sji.12718
– volume: 73
  year: 2013
  ident: B112
  article-title: Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-12-3450
– volume: 15
  start-page: R68
  year: 2013
  ident: B16
  article-title: Peripheral Regulatory Cells Immunophenotyping in Primary Sjögren’s Syndrome: A Cross-Sectional Study
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar4245
– volume: 52
  year: 2020
  ident: B59
  article-title: Plasmacytoid Dendritic Cells and Type I Interferon Promote Extrafollicular B Cell Responses to Extracellular Self-DNA
  publication-title: Immunity
  doi: 10.1016/j.immuni.2020.04.015
– volume: 51
  start-page: 57
  year: 2014
  ident: B122
  article-title: Differentiation of Follicular Helper T Cells by Salivary Gland Epithelial Cells in Primary Sjögren’s Syndrome
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2013.11.003
– start-page: 1
  year: 2020
  ident: B60
  article-title: Increased Expression of Interleukin-21-Inducible Genes in Minor Salivary Glands Are Associated With Primary Sjögren’s Syndrome Disease Characteristics
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keaa695
– volume: 116
  year: 1999
  ident: B96
  article-title: Elevated Serum Levels of Soluble Membrane Cofactor Protein (CD46, MCP) in Patients With Systemic Lupus Erythematosus (SLE)
  publication-title: Clin Exp Immunol
  doi: 10.1046/j.1365-2249.1999.00917.x
– volume: 16
  start-page: R118
  year: 2014
  ident: B14
  article-title: B Cell Subsets and Dysfunction of Regulatory B Cells in IgG4-Related Diseases and Primary Sjögren’s Syndrome: The Similarities and Differences
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar4571
– volume: 44
  year: 2011
  ident: B39
  article-title: Distinct Phenotypes of Plasma Cells in Spleen and Bone Marrow of Autoimmune NOD.B10.H2b Mice
  publication-title: Autoimmunity
  doi: 10.3109/08916934.2010.545847
– volume: 14
  year: 2017
  ident: B40
  article-title: Proteasome Inhibition Suppresses Th17 Cell Generation and Ameliorates Autoimmune Development in Experimental Sjögren’s Syndrome
  publication-title: Cell Mol Immunol
  doi: 10.1038/cmi.2017.8
– volume: 65
  year: 2013
  ident: B67
  article-title: Expansion of Autoreactive Unresponsive CD21–/Low B Cells in Sjögren’s Syndrome–Associated Lymphoproliferation
  publication-title: Arthritis Rheum
  doi: 10.1002/art.37828
– volume: 184
  year: 2019
  ident: B74
  article-title: Rituximab-Bendamustine (R-Benda) in MALT Lymphoma Complicating Primary Sjögren Syndrome (Pss)
  publication-title: Br J Haematol
  doi: 10.1111/bjh.15120
– volume: 14
  year: 2008
  ident: B83
  article-title: The Proteasome Inhibitor Bortezomib Depletes Plasma Cells and Protects Mice With Lupus-Like Disease From Nephritis
  publication-title: Nat Med
  doi: 10.1038/nm1763
– volume: 198
  year: 2017
  ident: B31
  article-title: Age-Associated B Cells Express a Diverse Repertoire of VH and Vκ Genes With Somatic Hypermutation
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1601106
– volume: 181
  year: 2015
  ident: B117
  article-title: Remission of Systemic Lupus Erythematosus Disease Activity With Regulatory Cytokine Interleukin (IL)-35 in Murphy Roths Large (MRL)/Lpr Mice
  publication-title: Clin Exp Immunol
  doi: 10.1111/cei.12639
– volume: 81
  year: 2017
  ident: B21
  article-title: Fcrl4+ B-Cells in Salivary Glands of Primary Sjögren’s Syndrome Patients
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2017.03.012
– volume: 9
  start-page: 1758
  year: 2018
  ident: B50
  article-title: Il-21 Drives Expansion and Plasma Cell Differentiation of Autoreactive CD11chi T-Bet+ B Cells in SLE
  publication-title: Nat Commun
  doi: 10.1038/s41467-018-03750-7
– volume: 74
  year: 2015
  ident: B106
  article-title: Th17 Cells Play a Critical Role in the Development of Experimental Sjögren’s Syndrome
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-204584
– volume: 8
  start-page: e41641
  year: 2019
  ident: B58
  article-title: Ifnγ Induces Epigenetic Programming of Human T-Bethi B Cells and Promotes TLR7/8 and IL-21 Induced Differentiation
  publication-title: Elife
  doi: 10.7554/eLife.41641
– volume: 52
  year: 2005
  ident: B35
  article-title: Dysregulation of Chemokine Receptor Expression and Function by B Cells of Patients With Primary Sjögren’s Syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21129
– year: 2020
  ident: B77
  article-title: Il-17 Sustains the Plasma Cell Response Via P38-Mediated Bcl-xL RNA Stability in Lupus Pathogenesis
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-020-00540-4
– volume: 22
  year: 2011
  ident: B80
  article-title: Myeloperoxidase-Specific Plasma Cell Depletion by Bortezomib Protects From Anti-Neutrophil Cytoplasmic Autoantibodies–Induced Glomerulonephritis
  publication-title: J Am Soc Nephrol
  doi: 10.1681/ASN.2010010034
– volume: 186
  year: 2011
  ident: B81
  article-title: Proteasome Inhibition With Bortezomib Depletes Plasma Cells and Autoantibodies in Experimental Autoimmune Myasthenia Gravis
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1002539
– volume: 79
  year: 2020
  ident: B121
  article-title: Salivary Gland Epithelial Cells From Patients With Sjögren’s Syndrome Induce B-Lymphocyte Survival and Activation
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2019-216588
– volume: 21
  year: 2015
  ident: B86
  article-title: Refractory Primary Sjögren Syndrome Successfully Treated With Bortezomib
  publication-title: J Clin Rheumatol
  doi: 10.1097/RHU.0000000000000210
– volume: 18
  year: 2021
  ident: B123
  article-title: New Insights Into Follicular Helper T Cell Response and Regulation in Autoimmune Pathogenesis
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-021-00688-7
– volume: 12
  year: 2016
  ident: B90
  article-title: Plasma Cells as an Innovative Target in Autoimmune Disease With Renal Manifestations
  publication-title: Nat Rev Nephrol
  doi: 10.1038/nrneph.2016.20
– volume: 11
  year: 2020
  ident: B57
  article-title: Cd11c+ B Cells Are Mainly Memory Cells, Precursors of Antibody Secreting Cells in Healthy Donors
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.00032
– volume: 56
  year: 2016
  ident: B28
  article-title: Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus
  publication-title: J Clin Pharmacol
  doi: 10.1002/jcph.686
– volume: 48
  year: 2003
  ident: B6
  article-title: Cellular Basis of Ectopic Germinal Center Formation and Autoantibody Production in the Target Organ of Patients With Sjögren’s Syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.11311
– volume: 14
  year: 2005
  ident: B47
  article-title: Anti-B Cell Therapy (Rituximab) in the Treatment of Autoimmune Diseases
  publication-title: Lupus
  doi: 10.1191/0961203305lu2138oa
– volume: 14
  start-page: R86
  year: 2012
  ident: B62
  article-title: Serum BAFF and APRIL Levels in Patients With IgG4-Related Disease and Their Clinical Significance
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3810
– volume: 202
  start-page: 496
  year: 2004
  ident: B64
  article-title: Expression of BAFF (BlyS) in T Cells Infiltrating Labial Salivary Glands From Patients With Sjögren’s Syndrome
  publication-title: J Pathol
  doi: 10.1002/path.1533
– volume: 9
  start-page: 218
  year: 2007
  ident: B76
  article-title: B Cells in Sjögren’s Syndrome: Indications for Disturbed Selection and Differentiation in Ectopic Lymphoid Tissue
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar2210
– volume: 7
  year: 2011
  ident: B91
  article-title: Long-Lived Autoreactive Plasma Cells Drive Persistent Autoimmune Inflammation
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2011.1
– year: 2019
  ident: B66
  article-title: A Human Recombinant Fusion Protein Targeting B Lymphocyte Stimulator (BlyS) and a Proliferation-Inducing Ligand (April), Telitacicept (RC18)
– volume: 37
  year: 1998
  ident: B23
  article-title: Chemokine Expression and Leucocyte Infiltration in Sjögren’s Syndrome
  publication-title: Br J Rheumatol
  doi: 10.1093/rheumatology/37.7.779
– volume: 244
  year: 2018
  ident: B116
  article-title: Interleukin-35 as a New Biomarker of Renal Involvement in Lupus Nephritis Patients
  publication-title: Tohoku J Exp Med
  doi: 10.1620/tjem.244.263
– volume: 195
  year: 2015
  ident: B53
  article-title: Cd11c-Expressing B Cells Are Located at the T Cell/B Cell Border in Spleen and Are Potent Apcs
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1500055
– volume: 90
  year: 1997
  ident: B73
  article-title: Lymphomas in Patients With Sjögren’s Syndrome are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses
  publication-title: Blood
  doi: 10.1182/blood.V90.2.766
– volume: 25
  year: 2007
  ident: B17
  article-title: Fc Receptor-Like Molecules
  publication-title: Annu Rev Immunol
  doi: 10.1146/annurev.immunol.25.022106.141541
– volume: 118
  year: 2011
  ident: B94
  article-title: Fc Gamma Receptor IIb on Target B Cells Promotes Rituximab Internalization and Reduces Clinical Efficacy
  publication-title: Blood
  doi: 10.1182/blood-2011-01-330357
– volume: 160
  year: 2014
  ident: B92
  article-title: Treatment of Primary Sjögren Syndrome With Rituximab
  publication-title: Ann Intern Med
  doi: 10.7326/M13-1085
– volume: 107
  year: 2006
  ident: B56
  article-title: AID Expression Identifies Interfollicular Large B Cells as Putative Precursors of Mature B-Cell Malignancies
  publication-title: Blood
  doi: 10.1182/blood-2005-06-2502
– volume: 54
  year: 2014
  ident: B87
  article-title: Bortezomib for Chronic Relapsing Thrombotic Thrombocytopenic Purpura: A Case Report
  publication-title: Transfusion
  doi: 10.1111/trf.12614
– volume: 174
  year: 2005
  ident: B34
  article-title: Analysis of Marginal Zone B Cell Development in the Mouse With Limited B Cell Diversity: Role of the Antigen Receptor Signals in the Recruitment of B Cells to the Marginal Zone
  publication-title: J Immunol
  doi: 10.4049/jimmunol.174.3.1438
– volume: 118
  year: 2011
  ident: B24
  article-title: A B-cell Subset Uniquely Responsive to Innate Stimuli Accumulates in Aged Mice
  publication-title: Blood
  doi: 10.1182/blood-2011-01-330530
– volume: 7
  year: 2014
  ident: B37
  article-title: CD4+CXCR5+ Follicular Helper T Cells in Salivary Gland Promote B Cells Maturation in Patients With Primary Sjogren’s Syndrome
  publication-title: Int J Clin Exp Pathol
– volume: 32
  year: 2010
  ident: B41
  article-title: Cd19+Cd24hicd38hi B Cells Exhibit Regulatory Capacity in Healthy Individuals But Are Functionally Impaired in Systemic Lupus Erythematosus Patients
  publication-title: Immunity
  doi: 10.1016/j.immuni.2009.11.009
– volume: 49
  year: 2018
  ident: B46
  article-title: Lag-3 Inhibitory Receptor Expression Identifies Immunosuppressive Natural Regulatory Plasma Cells
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.06.007
– volume: 176
  year: 2006
  ident: B98
  article-title: A Case for Regulatory B Cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.176.2.705
– volume: 24
  year: 2015
  ident: B115
  article-title: Aberrant Expression of Regulatory Cytokine IL-35 in Patients With Systemic Lupus Erythematosus
  publication-title: Lupus
  doi: 10.1177/0961203315585815
– volume: 16
  year: 2019
  ident: B42
  article-title: Il-10-Producing Regulatory B Cells Restrain the T Follicular Helper Cell Response in Primary Sjögren’s Syndrome
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-019-0227-z
– volume: 46
  year: 2002
  ident: B75
  article-title: Diminished Peripheral Blood Memory B Cells and Accumulation of Memory B Cells in the Salivary Glands of Patients With Sjögren’s Syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.10445
– volume: 110
  year: 2013
  ident: B26
  article-title: T-Box Transcription Factor T-Bet, a Key Player in a Unique Type of B-Cell Activation Essential for Effective Viral Clearance
  publication-title: Proc Natl Acad Sci USA
  doi: 10.1073/pnas.1312348110
– volume: 507
  year: 2014
  ident: B44
  article-title: IL-35-Producing B Cells Are Critical Regulators of Immunity During Autoimmune and Infectious Diseases
  publication-title: Nature
  doi: 10.1038/nature12979
– volume: 55
  year: 2018
  ident: B118
  article-title: Natural Regulatory Plasma Cells
  publication-title: Curr Opin Immunol
  doi: 10.1016/j.coi.2018.09.012
– volume: 180
  year: 2012
  ident: B108
  article-title: Il-10–Producing Regulatory B10 Cells Ameliorate Collagen-Induced Arthritis Via Suppressing Th17 Cell Generation
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2012.03.010
– volume: 168
  year: 2016
  ident: B8
  article-title: Central Role for Marginal Zone B Cells in an Animal Model of Sjogren’s Syndrome
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2016.04.008
– volume: 69
  year: 2017
  ident: B33
  article-title: Defective Early B Cell Tolerance Checkpoints in Sjögren’s Syndrome Patients
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40215
– volume: 109
  year: 2020
  ident: B22
  article-title: Gene Expression Profiling of Epithelium-Associated Fcrl4+ B Cells in Primary Sjögren’s Syndrome Reveals a Pathogenic Signature
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2020.102439
– volume: 127
  year: 2017
  ident: B52
  article-title: B Cells Expressing the Transcription Factor T-Bet Drive Lupus-Like Autoimmunity
  publication-title: J Clin Invest
  doi: 10.1172/JCI91250
– volume: 69
  year: 2017
  ident: B30
  article-title: Enhanced Bruton’s Tyrosine Kinase Activity in Peripheral Blood B Lymphocytes From Patients With Autoimmune Disease
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40059
– volume: 17
  year: 2021
  ident: B119
  article-title: Epithelial–Immune Cell Interplay in Primary Sjögren Syndrome Salivary Gland Pathogenesis
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/s41584-021-00605-2
– volume: 6
  year: 2007
  ident: B9
  article-title: Polarization of B Effector Cells in Sjögren’s Syndrome
  publication-title: Autoimmun Rev
  doi: 10.1016/j.autrev.2007.01.010
– volume: 197
  start-page: 489
  year: 2003
  ident: B103
  article-title: Prevention of Arthritis by Interleukin 10–Producing B Cells
  publication-title: J Exp Med
  doi: 10.1084/jem.20021293
– volume: 1274
  start-page: 48
  year: 2012
  ident: B89
  article-title: Targeting Plasma Cells With Proteasome Inhibitors: Possible Roles in Treating Myasthenia Gravis
  publication-title: Ann NY Acad Sci
  doi: 10.1111/j.1749-6632.2012.06824.x
– volume: 8
  year: 2017
  ident: B11
  article-title: The Other Function: Class II-Restricted Antigen Presentation by B Cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00319
– volume: 18
  year: 2006
  ident: B20
  article-title: Expression Pattern of the Human FcRH/IRTA Receptors in Normal Tissue and in B-Chronic Lymphocytic Leukemia
  publication-title: Int Immunol
  doi: 10.1093/intimm/dxl069
– volume: 74
  year: 2015
  ident: B65
  article-title: Efficacy and Safety of Belimumab in Primary Sjögren’s Syndrome: Results of the BELISS Open-Label Phase II Study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203991
– volume: 13
  start-page: 227
  year: 2011
  ident: B10
  article-title: Disturbance of Cytokine Networks in Sjögren’s Syndrome
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar3348
– volume: 44
  start-page: 49
  year: 2017
  ident: B48
  article-title: B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome
  publication-title: J Rheumatol
  doi: 10.3899/jrheum.160313
– volume: 90
  start-page: e12792
  year: 2019
  ident: B69
  article-title: CD21–/Low B Cells Associate With Joint Damage in Rheumatoid Arthritis Patients
  publication-title: Scand J Immunol
  doi: 10.1111/sji.12792
– volume: 54
  year: 2015
  ident: B29
  article-title: Amplification of IL-21 Signalling Pathway Through Bruton’s Tyrosine Kinase in Human B Cell Activation
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/keu532
– volume: 20
  year: 2020
  ident: B63
  article-title: Expression of BAFF and BAFF Receptors in Primary Sjögren’s Syndrome Patients With Ectopic Germinal Center-Like Structures
  publication-title: Clin Exp Med
  doi: 10.1007/s10238-020-00637-0
– volume: 17
  year: 2020
  ident: B12
  article-title: The Expanding Functional Diversity of Plasma Cells in Immunity and Inflammation
  publication-title: Cell Mol Immunol
  doi: 10.1038/s41423-019-0308-z
– volume: 41
  year: 2014
  ident: B102
  article-title: Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
  publication-title: Immunity
  doi: 10.1016/j.immuni.2014.10.016
– volume: 79
  year: 2020
  ident: B61
  article-title: Unique Expansion of IL-21+ Tfh and Tph Cells Under Control of ICOS Identifies Sjögren’s Syndrome With Ectopic Germinal Centres and MALT Lymphoma
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-217646
– volume: 6
  year: 2010
  ident: B5
  article-title: Pathogenetic Mechanisms in the Initiation and Perpetuation of Sjögren’s Syndrome
  publication-title: Nat Rev Rheumatol
  doi: 10.1038/nrrheum.2010.118
– volume: 8
  year: 2017
  ident: B113
  article-title: Impairment of Granzyme B-Producing Regulatory B Cells Correlates With Exacerbated Rheumatoid Arthritis
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2017.00768
– volume: 17
  start-page: 39
  year: 2015
  ident: B82
  article-title: Long-Lived Plasma Cells Are Early and Constantly Generated in New Zealand Black/New Zealand White F1 Mice and Their Therapeutic Depletion Requires a Combined Targeting of Autoreactive Plasma Cells and Their Precursors
  publication-title: Arthritis ResTher
  doi: 10.1186/s13075-015-0551-3
– volume: 215
  year: 2018
  ident: B107
  article-title: Deficiency in T Follicular Regulatory Cells Promotes Autoimmunity
  publication-title: J Exp Med
  doi: 10.1084/jem.20170901
– volume: 8
  start-page: R51
  year: 2006
  ident: B78
  article-title: B Cell-Activating Factor of the Tumor Necrosis Factor Family (BAFF) Is Expressed Under Stimulation by Interferon in Salivary Gland Epithelial Cells in Primary Sjögren’s Syndrome
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar1912
– volume: 10
  year: 2019
  ident: B111
  article-title: April Induces a Novel Subset of IgA+ Regulatory B Cells That Suppress Inflammation Via Expression of IL-10 and PD-L1
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2019.01368
– volume: 49
  year: 2018
  ident: B49
  article-title: Distinct Effector B-Cells Induced by Unregulated Toll-Like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus
  publication-title: Immunity
  doi: 10.1016/j.immuni.2018.08.015
– volume: 40
  year: 2019
  ident: B27
  article-title: B Cell Alterations During BAFF Inhibition With Belimumab in SLE
  publication-title: EBioMedicine
  doi: 10.1016/j.ebiom.2018.12.035
– volume: 366
  year: 2005
  ident: B2
  article-title: Sjögren’s Syndrome
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)66990-5
– volume: 11
  year: 2020
  ident: B70
  article-title: The Antigen Presenting Potential of CD21low B Cells
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2020.535784
– volume: 69
  year: 2017
  ident: B93
  article-title: Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren’s Syndrome
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.40093
– volume: 79
  year: 2020
  ident: B97
  article-title: Efficacity of a Sequential Treatment by Anti-CD 20 Monoclonal Antibody and Belimumab in Type II Cryoglobulinaemia Associated With Primary Sjögren Syndrome Refractory to Rituximab Alone
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-21748
– volume: 61
  year: 2014
  ident: B85
  article-title: Bortezomib for Effective Treatment of a Child With Refractory Autoimmune Hemolytic Anemia Post Allogeneic Hematopoietic Stem Cell Transplant
  publication-title: Pediatr Blood Cancer
  doi: 10.1002/pbc.25172
– volume: 113
  year: 2004
  ident: B68
  article-title: A New CD21low B Cell Population in the Peripheral Blood of Patients With SLE
  publication-title: Clin Immunol
  doi: 10.1016/j.clim.2004.05.010
– volume: 101
  year: 2019
  ident: B32
  article-title: Abatacept Modulates CD80 and CD86 Expression and Memory Formation in Human B-Cells
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2019.04.016
– volume: 137
  year: 2016
  ident: B15
  article-title: In-Depth Characterization of CD24 High CD38 High Transitional Human B Cells Reveals Different Regulatory Profiles
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2015.09.014
– volume: 51
  year: 2012
  ident: B79
  article-title: The Expression of APRIL in Sjögren’s Syndrome: Aberrant Expression of APRIL in the Salivary Gland
  publication-title: Rheumatology
  doi: 10.1093/rheumatology/kes080
– volume: 2016
  year: 2016
  ident: B43
  article-title: Increased IL-21 Expression Induces Granzyme B in Peripheral Cd5+ B Cells as a Potential Counter-Regulatory Effect in Primary Sjögren’s Syndrome
  publication-title: Mediators Inflammation
  doi: 10.1155/2016/4328372
– volume: 378
  year: 2018
  ident: B1
  article-title: Primary Sjögren’s Syndrome
  publication-title: N Engl J Med
  doi: 10.1056/NEJMcp1702514
– volume: 197
  year: 2016
  ident: B51
  article-title: Age-Associated B Cells With Proinflammatory Characteristics Are Expanded in a Proportion of Multiple Sclerosis Patients
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1502448
– volume: 102
  year: 2003
  ident: B54
  article-title: Phenotype and Genotype of Interfollicular Large B Cells, A Subpopulation of Lymphocytes Often With Dendritic Morphology
  publication-title: Blood
  doi: 10.1182/blood-2003-03-0692
– volume: 20
  year: 2014
  ident: B45
  article-title: Interleukin-35 Induces Regulatory B Cells That Suppress Cns Autoimmune Disease
  publication-title: Nat Med
  doi: 10.1038/nm.3554
– volume: 67
  year: 2015
  ident: B7
  article-title: Prediction of Sjögren’s Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling
  publication-title: Arthritis Rheumatol
  doi: 10.1002/art.39214
– volume: 38
  year: 2020
  ident: B3
  article-title: Pathogenesis of Primary Sjögren’s Syndrome Beyond B Lymphocytes
  publication-title: Clin Exp Rheumatol
– volume: 118
  year: 2011
  ident: B25
  article-title: Toll-Like Receptor 7 (TLR7)–Driven Accumulation of a Novel CD11c+ B-Cell Population Is Important for the Development of Autoimmunity
  publication-title: Blood
  doi: 10.1182/blood-2011-01-331462
– volume: 117
  year: 2011
  ident: B101
  article-title: Characterization of a Rare IL-10–Competent B-Cell Subset in Humans That Parallels Mouse Regulatory B10 Cells
  publication-title: Blood
  doi: 10.1182/blood-2010-07-294249
– volume: 184
  year: 2010
  ident: B109
  article-title: Cutting Edge: Novel Function of B Cell-Activating Factor in the Induction of IL-10–Producing Regulatory B Cells
  publication-title: J Immunol
  doi: 10.4049/jimmunol.0902551
– volume: 54
  year: 2006
  ident: B71
  article-title: Identification of Transitional Type II B Cells in the Salivary Glands of Patients With Sjögren’s Syndrome
  publication-title: Arthritis Rheum
  doi: 10.1002/art.21936
– volume: 72
  year: 2013
  ident: B120
  article-title: Op0079 Salivary Gland Epithelial Cells (SGECS) Promote the Differentiation of B Cells
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-eular.284
– volume: 186
  year: 1997
  ident: B100
  article-title: Suppressive Role of B Cells in Chronic Colitis of T Cell Receptor α Mutant Mice
  publication-title: J Exp Med
  doi: 10.1084/jem.186.10.1749
SSID ssj0000493335
Score 2.501998
SecondaryResourceType review_article
Snippet Primary Sjögren’s syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as...
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease characterized by lymphocytic infiltration and tissue destruction of exocrine glands such as...
SourceID doaj
pubmedcentral
proquest
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
StartPage 684999
SubjectTerms B cells
Immunology
pathogenesis
primary Sjögren’s syndrome
regulatory functions
treatment
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSgMxFA1SENyIT6wvIrgSxs4rM8nSFkspVMQquAuZPLSlnYptF-78DX_EH_BP_BJvMtPS2ejGbZJhMvfeyT2HXM5F6FwomjBgPh6AVd-LFZGeoKnxAOqrkGRx5jui2LtJOg9x95E8rrT6sjVhhTxwYbhGRIWSOgW-BJETS8ZkGKgwSRNBqSKhsacv5LwVMjUscG8URaS4xgQWxhpmMB7PgQ-GwWVCLcyvJCKn118BmdUSyZWc095CmyVYxFfFJrfRms530HrRPvJtF3XBx7hXVgTiOyvNhCcGN3FLj0ZTPMgxoDt8Cxhv8mSPtIGb7g-_PoFk59_vH1PcLwUL9tBD-_q-1fHK3gieBEg182RmMhaEkN_TwBgBqEAnkIyV72uaqUBTGhmrjZelUZwQJpmSvsxSAfmaqRBG91Etn-T6AGGTUCJ0zESggSxrQg0lylehpEIKxaI68heG4rIUDrf9K0YcCIS1LXe25da2vLBtHV0sH3kpVDN-W9y01l8utILXbgDCgJdhwP8Kgzo6W_iOww9ibz1ErifzKQcG7FgTi-sorTi18sbqTD54dlLbFBgbnHCH_7HFI7Rhv9rVmdFjVJu9zvUJIJpZduqC9wehDfVt
  priority: 102
  providerName: Directory of Open Access Journals
Title The Multiple Roles of B Cells in the Pathogenesis of Sjögren’s Syndrome
URI https://www.proquest.com/docview/2545597494
https://pubmed.ncbi.nlm.nih.gov/PMC8217880
https://doaj.org/article/38adce75237944c99c21d2676a88d52f
Volume 12
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LShxBFL0Yg8FNiFHJJEYqkJXQ2q-qrloEUYmKMCGoA7MrquthRsZunQfEXX4jP5IfyJ_kS7xV3SNpkCyy6UU9aPreqnvP6SrOBfioDGcCmU-EYDWOckN1pHjhIoT6JqVlXsaBKPa_sNNBfjakwyVYlLdqDTh9ktr5elKDyXj3-939Pm74T55xYr7dc6ObmzlSvTTZZdwj-GfwHBNT4Qsa9Fu0f92A4SzLaHO2-fTMVXiBYZ1xRrNOogp6_h0Q2r1C-VdOOn4FL1swSQ4a76_Bkq1ew0pTXvJ-Hc5wDZB-e2OQnHvpJlI7ckiO7Hg8JaOKIPojXxED1lc-5I1C98X1719Iwqs_P35OyUUraLABg-PPl0enUVs7IdIIuWaRLl0pkhTzf5E4pxA1WIY2MXFseWkSy3nmvHZeWWQ5o0ILo2NdFgrzuTAptm7CclVX9g0QxzhVNhcqsUimLeWOUxObVHOllRFZD-KFoaRuhcV9fYuxRILhzSyDmaU3s2zM3IOdxym3jarGvwYfeus_DvSC2KGhnlzJdn_JjCv0RYG0GgNMroXQaWJSVjDFuaGp68GHhe8kbiB_KqIqW8-nEhlyYFUi70HRcWrnjd2eavQtSHFzZHQYAd_-98x3sOo_NVw-41uwPJvM7XuEObNyO_wewOfJMNkOC_kBcHMArg
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Multiple+Roles+of+B+Cells+in+the+Pathogenesis+of+Sj%C3%B6gren%E2%80%99s+Syndrome&rft.jtitle=Frontiers+in+immunology&rft.au=Du%2C+Wenhan&rft.au=Han%2C+Man&rft.au=Zhu%2C+Xiaoxia&rft.au=Xiao%2C+Fan&rft.date=2021-06-08&rft.pub=Frontiers+Media+S.A&rft.eissn=1664-3224&rft.volume=12&rft_id=info:doi/10.3389%2Ffimmu.2021.684999&rft_id=info%3Apmid%2F34168653&rft.externalDocID=PMC8217880
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1664-3224&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1664-3224&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1664-3224&client=summon